39 related articles for article (PubMed ID: 17021427)
1. Radioiodine Scan Index: A Simplified, Quantitative Treatment Response Parameter for Metastatic Thyroid Carcinoma.
Oh JR; Ahn BC; Jeong SY; Lee SW; Lee J
Nucl Med Mol Imaging; 2015 Sep; 49(3):174-81. PubMed ID: 26279690
[TBL] [Abstract][Full Text] [Related]
2. Impact of age on tumor characteristics and treatment outcomes in pediatric Differentiated Thyroid Carcinoma.
Garcia JC; de Assumpção LVM; Parisi MCR; Zantut-Wittmann DE
Endocrine; 2024 May; ():. PubMed ID: 38748202
[TBL] [Abstract][Full Text] [Related]
3. Unexpected
Liu J; Li X; Li L; Yin Y; Cai H; Yi H
Am J Nucl Med Mol Imaging; 2024; 14(1):63-71. PubMed ID: 38500743
[TBL] [Abstract][Full Text] [Related]
4. Importance of measurement of thyroglobulin and anti-thyroglobulin antibodies in differentiated thyroid cancer.
Alagić-Smailbegović J; Kucukalić-Selimović E; Setić I; Bećirović M; Begović L
Coll Antropol; 2012 Nov; 36 Suppl 2():33-8. PubMed ID: 23397752
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine whole-body scans, thyroglobulin levels, 99mTc-MIBI scans and computed tomography: results in patients with lung metastases from differentiated thyroid cancer.
Küçük ON; Gültekin SS; Aras G; Ibiş E
Nucl Med Commun; 2006 Mar; 27(3):261-6. PubMed ID: 16479246
[TBL] [Abstract][Full Text] [Related]
6. Clinical importance of technetium-99m-methoxyisobutylisonitrile (MIBI) scintigraphy in differentiated thyroid carcinoma patients with elevated thyroglobulin levels and negative I-131 scanning results.
Küçük NO; Külak HA; Aras G
Ann Nucl Med; 2006 Jul; 20(6):393-7. PubMed ID: 16922467
[TBL] [Abstract][Full Text] [Related]
7. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
[TBL] [Abstract][Full Text] [Related]
8. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.
Rubello D; Mazzarotto R; Casara D
Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117
[TBL] [Abstract][Full Text] [Related]
9. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
[TBL] [Abstract][Full Text] [Related]
10. Clinical importance of anti-thyroglobulin auto-antibodies in patients with differentiated thyroid carcinoma: comparison with 99mTc-MIBI scans.
Küçük ON; Aras G; Kulak HA; Ibiş E
Nucl Med Commun; 2006 Nov; 27(11):873-6. PubMed ID: 17021427
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic modalities in patients affected by differentiated thyroid carcinoma with high thyroglobulin levels and total body Iodium-131 negative: PET/CT use after recTSH].
Biscontini G; Possa M; Sara R; Milella M; Rossetti C
Minerva Endocrinol; 2004 Dec; 29(4):151-60. PubMed ID: 15765025
[TBL] [Abstract][Full Text] [Related]
12. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
